MedTrace Logo

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.

NCT00264043 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-08-06

No results posted yet for this study

Summary

The primary objective is to evaluate the use of the AngioGuard™ device combined with the Bx Velocity™ on patient outcome at one month.

Conditions

Interventions

DEVICE

emboli capturing guidewire device combined with stent

AngioGuard™ device and Bx Velocity™ stent

Sponsors & Collaborators

  • Cordis Corporation

    lead INDUSTRY

Principal Investigators

  • Eberhard Grube, MD · Herzzentrum Siegburg GMBH

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31
Primary Completion
2002-02-28
Completion
2002-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264043 on ClinicalTrials.gov